Data gathered: November 27
Alternative Data for Clearside Biomedical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Google Trends | 5 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,059 | Sign up | Sign up | Sign up |
| Twitter Followers | 247 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 41 | Sign up | Sign up | Sign up |
About Clearside Biomedical
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.
| Price | $1.07 |
| Target Price | Sign up |
| Volume | 176,550 |
| Market Cap | $82M |
| Year Range | $0.93 - $1.8 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United StatesNovember 24 - Yahoo |
 |
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Consensus Rating of “Buy” from BrokeragesNovember 21 - ETF Daily News |
 |
Clearside Biomedical (NASDAQ:CLSD) Upgraded at StockNews.comNovember 18 - ETF Daily News |
|
Clearside Biomedical’s (CLSD) Buy Rating Reiterated at Chardan CapitalNovember 18 - ETF Daily News |
 |
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to BuyNovember 15 - Yahoo |
 |
Clearside Biomedical Third Quarter 2024 Earnings: Beats ExpectationsNovember 14 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1M | 2.8M | -1.8M | -7.7M | -5.9M | -0.100 |
| Q2 '24 | 90,000 | 3.1M | -3M | -7.6M | -5.2M | -0.100 |
| Q1 '24 | 230,000 | 2.8M | -2.6M | -12M | -9.3M | -0.150 |
| Q4 '23 | 6.3M | 2.9M | 3.4M | -4.8M | -2.5M | -0.080 |
| Q3 '23 | 860,000 | 2.8M | -1.9M | -9.3M | -7.1M | -0.150 |
Insider Transactions View All
| Chong Ngai Hang Victor filed to buy 100,000 shares at $1. November 4 '24 |
| Chong Ngai Hang Victor filed to buy 63,500 shares at $1.1. June 24 '24 |
| YERXA BENJAMIN R filed to buy 17,957 shares at $1.3. May 15 '24 |
| Gibney Anthony S filed to buy 100,000 shares at $1.3. April 19 '24 |
| Gibney Anthony S filed to buy 6,710 shares at $1.3. April 19 '24 |
Similar companies
Read more about Clearside Biomedical (CLSD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Clearside Biomedical?
The Market Cap of Clearside Biomedical is $82M.
What is the current stock price of Clearside Biomedical?
Currently, the price of one share of Clearside Biomedical stock is $1.07.
How can I analyze the CLSD stock price chart for investment decisions?
The CLSD stock price chart above provides a comprehensive visual representation of Clearside Biomedical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Clearside Biomedical shares. Our platform offers an up-to-date CLSD stock price chart, along with technical data analysis and alternative data insights.
Does CLSD offer dividends to its shareholders?
As of our latest update, Clearside Biomedical (CLSD) does not offer dividends to its shareholders. Investors interested in Clearside Biomedical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Clearside Biomedical?
Some of the similar stocks of Clearside Biomedical are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.